Boothbay Fund Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $951K | Buy |
+13,777
| New | +$951K | 0.02% | 537 |
|
|
2025
Q1 | – | Sell |
-22,833
| Closed | -$1.96M | – | 1490 |
|
|
2024
Q4 | $1.96M | Sell |
22,833
-43,439
| -66% | -$3.74M | 0.05% | 377 |
|
|
2024
Q3 | $7.89M | Buy |
66,272
+27,898
| +73% | +$3.32M | 0.18% | 112 |
|
|
2024
Q2 | $5.48M | Sell |
38,374
-18,589
| -33% | -$2.65M | 0.13% | 168 |
|
|
2024
Q1 | $7.31M | Buy |
56,963
+36,368
| +177% | +$4.67M | 0.14% | 102 |
|
|
2023
Q4 | $2.13M | Buy |
20,595
+13,820
| +204% | +$1.43M | 0.05% | 376 |
|
|
2023
Q3 | $616K | Buy |
6,775
+1,889
| +39% | +$172K | 0.01% | 792 |
|
|
2023
Q2 | $395K | Sell |
4,886
-2,186
| -31% | -$177K | 0.01% | 1009 |
|
|
2023
Q1 | $563K | Sell |
7,072
-23,484
| -77% | -$1.87M | 0.01% | 1005 |
|
|
2022
Q4 | $2.07M | Sell |
30,556
-71,210
| -70% | -$4.82M | 0.05% | 482 |
|
|
2022
Q3 | $5.07M | Sell |
101,766
-46,848
| -32% | -$2.33M | 0.13% | 158 |
|
|
2022
Q2 | $8.28M | Buy |
148,614
+21,284
| +17% | +$1.19M | 0.22% | 59 |
|
|
2022
Q1 | $7.07M | Buy |
127,330
+37,048
| +41% | +$2.06M | 0.16% | 89 |
|
|
2021
Q4 | $5.06M | Buy |
90,282
+45,338
| +101% | +$2.54M | 0.12% | 150 |
|
|
2021
Q3 | $2.16M | Buy |
+44,944
| New | +$2.16M | 0.06% | 329 |
|
|
2021
Q2 | – | Sell |
-6,464
| Closed | -$218K | – | 1846 |
|
|
2021
Q1 | $218K | Buy |
+6,464
| New | +$218K | 0.01% | 1100 |
|
|
2020
Q2 | – | Sell |
-8,728
| Closed | -$263K | – | 947 |
|
|
2020
Q1 | $263K | Buy |
+8,728
| New | +$263K | 0.02% | 515 |
|